SPECCHIA, GIORGINA
 Distribuzione geografica
Continente #
NA - Nord America 3.600
EU - Europa 2.480
AS - Asia 2.087
SA - Sud America 239
AF - Africa 31
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.447
Nazione #
US - Stati Uniti d'America 3.565
CN - Cina 969
IE - Irlanda 710
UA - Ucraina 604
SG - Singapore 546
SE - Svezia 385
RU - Federazione Russa 383
BR - Brasile 199
HK - Hong Kong 190
TR - Turchia 160
FR - Francia 103
FI - Finlandia 98
GB - Regno Unito 82
IN - India 80
VN - Vietnam 70
DE - Germania 40
IT - Italia 34
AR - Argentina 19
CA - Canada 19
IQ - Iraq 17
MX - Messico 10
ZA - Sudafrica 10
BD - Bangladesh 9
CZ - Repubblica Ceca 9
AT - Austria 8
PK - Pakistan 8
PL - Polonia 6
UZ - Uzbekistan 6
AU - Australia 5
DZ - Algeria 5
JP - Giappone 5
LT - Lituania 5
EC - Ecuador 4
ES - Italia 4
EU - Europa 4
MA - Marocco 4
NL - Olanda 4
SA - Arabia Saudita 4
CO - Colombia 3
JM - Giamaica 3
KE - Kenya 3
LB - Libano 3
PY - Paraguay 3
UY - Uruguay 3
VE - Venezuela 3
BO - Bolivia 2
CL - Cile 2
CR - Costa Rica 2
EG - Egitto 2
ID - Indonesia 2
KZ - Kazakistan 2
MU - Mauritius 2
OM - Oman 2
PS - Palestinian Territory 2
TN - Tunisia 2
AZ - Azerbaigian 1
BE - Belgio 1
BN - Brunei Darussalam 1
CH - Svizzera 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 8.447
Città #
Dublin 708
Chandler 503
San Jose 493
Jacksonville 425
Dearborn 357
Nanjing 264
Singapore 263
Nyköping 210
Hong Kong 190
Ashburn 148
Beijing 128
Nanchang 118
Santa Clara 92
San Mateo 86
Princeton 85
Boardman 78
Wilmington 75
Lauterbourg 69
Moscow 65
Dallas 57
Shenyang 49
Jiaxing 42
Kunming 40
Tianjin 40
The Dalles 37
Woodbridge 26
Hebei 25
Ho Chi Minh City 23
Hangzhou 21
Changsha 20
Des Moines 19
New York 19
Zhengzhou 19
Jinan 17
Guangzhou 14
São Paulo 14
Changchun 13
Los Angeles 12
Shanghai 12
Chennai 11
Helsinki 11
Munich 11
Ningbo 11
Auburn Hills 10
Chicago 10
Frankfurt am Main 9
Charlotte 8
Hanoi 8
Lanzhou 8
London 8
Rio de Janeiro 8
San Francisco 8
Johannesburg 7
Brooklyn 6
Hilden 6
Norwalk 6
Tashkent 6
Toronto 6
Wuhan 6
Atlanta 5
Belo Horizonte 5
Brasília 5
Brno 5
Da Nang 5
Milan 5
Monza 5
Taizhou 5
Turku 5
Warsaw 5
Amsterdam 4
Baghdad 4
Boston 4
Houston 4
Leawood 4
Olomouc 4
Pelotas 4
Secaucus 4
Tokyo 4
Ann Arbor 3
Buffalo 3
Campo Grande 3
Caxias do Sul 3
Curitiba 3
Dhaka 3
Goiânia 3
Haiphong 3
Hải Dương 3
Jinhua 3
Kingston 3
Manchester 3
Nuremberg 3
Orem 3
Ottawa 3
Pittsburgh 3
Porto Alegre 3
Pune 3
Ramadi 3
Ribeirão Preto 3
Rome 3
San Antonio 3
Totale 5.192
Nome #
T-cell acute lymphoblastic leukemia occurring in a patient with acute promyelocytic leukemia. 148
Autoimmune myelofibrosis: report of three cases and review of the literature. 140
Mobilization of haematopoietic stem cells CD34+ in patients undergoing elective lung resection: observational pilot study 137
A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11). 133
Acute megakaryoblastic leukemia: experience of GIMEMA trials. 133
Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study. 127
A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome. 126
CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy. 125
Acute myeloblastic leukemia with minimal myeloid differentiation featuring a three-way translocation t(8;13;14) 125
E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features. 120
Adenosine deaminase activity in chronic lymphocytic leukemia: evaluation of lymphocytic ADA during and after treatment. 120
Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP-6 120
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 114
CIZ gene rearrangements in acute leukemia: report of a diagnostic FISH assay and clinical features of nine patients. 113
Acute mixed lineage leukemias. 112
A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1. 112
Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature 112
Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course. 111
A case of Sezary's syndrome with terminal "leukemic phase". 110
t(15;17) in acute promyelocytic leukemia is not associated with submicroscopic deletions on der(17) 110
Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients. 109
Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemia. 108
Extramedullary blast crisis in chronic myeloid leukemia 106
Angiogenesis and hereditary hemorrhagic telangiectasia. Rendu-Osler-Weber disease. 106
Continuous infusion chemotherapy with epirubicin and vincristine in relapsed and refractory acute leukemia. 106
Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy. 105
CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint. 105
Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia. 104
Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome. 104
Identification of new partner chromosomes involved in fusions with the ETV6 (TEL) gene in hematologic malignancies. 103
Submicroscopic deletions in an acute myeloid leukemia case with a four-way t(8;11;16;21). 103
Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cells. 102
A novel translocation t(2;9)(q14;p12) in AML-M2 with an uncommon phenotype: myeloperoxidase-positive and myeloid antigen-negative 101
Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia. 101
Non-treatment-related chronic myeloid leukemia as a second malignancy. 101
Doxorubicin and m-AMSA induced DNA damage in blast cells from AML patients. 100
Acute promyelocytic leukemia: morphological aspects. 98
Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases. 98
Detection of BCR/ABL rearrangements in adult acute lymphoblastic leukemia using a highly sensitive interphase fluorescence in situ hybridization method (D-FISH). 98
Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia. 96
Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia. 96
Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears 96
Fungemia in acute leukemia patients: a single institution's experience. 94
Sensitivity to imatinib but low frequency of the TEL/PDGFRb fusion protein in chronic myelomonocytic leukemia. 94
Molecular cytogenetic study of chromosomal instability at 1q21-32 in an adult acute lymphoblastic leukemia case. 93
Cytotoxic activity and mechanism of action of 5-Aza-2'-deoxycytidine in human CML cells. 93
Cytochemical "normal" and "abnormal" eosinophils in acute leukemias. 93
Pneumonia in acute leukemia patients during induction therapy: experience in a single institution. 93
Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes. 92
Concomitant tetrasomy 3q and trisomy 18 in CD5(-), CD13(+) chronic lymphocytic leukemia. 92
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. 91
Molecular cytogenetic characterization of a novel additional chromosomal aberration in blast crisis of a Ph-positive chronic myeloid leukemia. 91
Molecular cytogenetics characterization of a novel translocation involving chromosomes 17 and 19 in a Ph+ adult acute lymphoblastic leukaemia. 91
Monitoring of cardiac function on the basis of serum troponin I levels in patients with acute leukemia treated with anthracyclines. 91
Familial clustering of HTLV-I infection in southeastern Italy 90
Constitutive expression of IL-1 beta, M-CSF and c-fms during the myeloid blastic phase of chronic myelogenous leukaemia. 89
Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto. 89
Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemia. 89
Evaluation of leukemic contamination in peripheral blood stem cell leukaphereses vs bone marrow after consolidation therapy in acute myeloid leukemia: not a critical factor in outcome? 89
Typhlitis complicating induction therapy in adult acute myeloid leukemia. 88
Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated 'sanctuary'? 88
The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases. 87
Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group. Gruppo Italiano Malattie Ematologiche Maligne Dell'Adulto. 87
Ph positive acute lymphoblastic leukemia in adults: molecular and clinical studies. 87
Deletions on der(9) chromosome in adult Ph-positive acute lymphoblastic leukemia occur with a frequency similar to that observed in chronic myeloid leukemia. 87
Mitoxantrone and continuous infusion of cytosine arabinoside in refractory and relapsed acute lymphoblastic leukemia. 87
Monocytes with binding capacity to sheep red blood cells in a case of acute undifferentiated leukemia. 87
Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto. 86
Liquid chromatographic determination of urinary 5-methyl-2'-deoxycytidine and pseudouridine as potential biological markers for leukaemia. 86
Cytophagocytosis by the blast cells in acute myeloid leukemia. 86
Genomic deletions on the third chromosome involved in variant t(9;22) chronic myeloid leukaemia cases 86
Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. 85
Good and poor CD34+ cells mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells. 85
The MDR phenotype in acute nonlymphoid leukemia. 84
Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: a pilot study of the Italian cooperative group GIMEMA 83
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients. 82
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 81
Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study. 81
Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia. 80
Reciprocal translocation t(12;13)(p13;q14) in acute nonlymphoblastic leukemia: report and cytogenetic analysis of two cases. 80
Interleukin-1 and tumor necrosis factor production in acute non-lymphoid leukemia. 80
Hand-mirror (HM) cells in acute lymphoblastic leukaemia (A.L.L.). An attempt at cellular classification by morphometric analytical parameters using the S.A.M. (Shape Analytical Morphometry) system. 78
Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trials. 78
Therapy of molecular relapse in acute promyelocytic leukemia. 77
Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. 75
Immunophenotypic and molecular features of 'cuplike' acute myeloid leukemias 70
Totale 8.489
Categoria #
all - tutte 41.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.026


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/2022386 84 0 0 1 11 4 8 28 67 40 25 118
2022/20231.929 136 56 50 171 158 176 0 176 915 8 49 34
2023/2024246 78 11 16 16 28 49 3 12 3 1 2 27
2024/20251.130 50 7 6 53 44 149 135 60 315 88 106 117
2025/20261.750 81 72 131 205 87 136 396 227 222 125 37 31
Totale 8.489